Thyroid Cancer Global Clinical Trials Review, H1, 2016

  • ID: 3759256
  • Clinical Trials
  • Region: Global
  • 320 pages
  • GlobalData
1 of 5

FEATURED COMPANIES

  • AstraZeneca Plc
  • Bayer AG
  • Eisai Co., Ltd.
  • Exelixis, Inc.
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc
  • MORE
Thyroid Cancer Global Clinical Trials Review, H1, 2016

Summary

Our clinical trial report, “Thyroid Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Thyroid Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Thyroid Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Clinical Trial Reports are generated using our proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • AstraZeneca Plc
  • Bayer AG
  • Eisai Co., Ltd.
  • Exelixis, Inc.
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc
  • MORE
List of Tables

List of Figures

Report Guidance

Clinical Trials by Region

Clinical Trials and Average Enrollment by Country

Top Five Countries Contributing to Clinical Trials in Asia-Pacific

Top Five Countries Contributing to Clinical Trials in Europe

Top Countries Contributing to Clinical Trials in North America

Top Five Countries Contributing to Clinical Trials in Middle East and Africa

Top Five Countries Contributing to Clinical Trials in Central and South America

Clinical Trials by G7 Countries: Proportion of Thyroid Cancer to Oncology Clinical Trials

Clinical Trials by Phase in G7 Countries

Clinical Trials in G7 Countries by Trial Status

Clinical Trials by E7 Countries: Proportion of Thyroid Cancer to Oncology Clinical Trials

Clinical Trials by Phase in E7 Countries

Clinical Trials in E7 Countries by Trial Status

Clinical Trials by Phase

In Progress Trials by Phase

Clinical Trials by Trial Status

Clinical Trials by End Point Status

Subjects Recruited Over a Period of Time

Clinical Trials by Sponsor Type

Prominent Sponsors

Top Companies Participating in Thyroid Cancer Therapeutics Clinical Trials

Prominent Drugs

Latest Clinical Trials News on Thyroid Cancer

Mar 17, 2016: Blueprint Medicines to Present Preclinical Data on RET Inhibitors in an Oral Presentation at American Association for Cancer Research Annual Meeting

Mar 02, 2016: Chi-Med initiates sulfatinib Phase II clinical trial in thyroid cancer

Clinical Trial Profile Snapshots

Appendix

Abbreviations

Definitions

Research Methodology

Secondary Research

About us

Contact Us

Disclaimer

Source

List of Tables

Thyroid Cancer Therapeutics, Global, Clinical Trials by Region, 2016-

Thyroid Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016-

Thyroid Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016-

Thyroid Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016-

Thyroid Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2016-

Thyroid Cancer Therapeutics Clinical Trials, North America, Top Countries, 2016-

Thyroid Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016-

Thyroid Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016-

Proportion of Thyroid Cancer to Oncology Clinical Trials, G7 Countries (%), 2016-

Thyroid Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2016-

Thyroid Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016-

Proportion of Thyroid Cancer to Oncology Clinical Trials, E7 Countries (%), 2016-

Thyroid Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2016-

Thyroid Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016-

Thyroid Cancer Therapeutics, Global, Clinical Trials by Phase, 2016-

Thyroid Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2016-

Thyroid Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2016-

Thyroid Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2016-

Thyroid Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015

Thyroid Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016-

Thyroid Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2016-

Thyroid Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016-

Thyroid Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016-

List of Figures

Thyroid Cancer Therapeutics, Global, Clinical Trials by Region (%), 2016-

Thyroid Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016-

Thyroid Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016-

Thyroid Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016-

Thyroid Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016-

Thyroid Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2016-

Thyroid Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016-

Thyroid Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016-

Proportion of Thyroid Cancer to Oncology Clinical Trials, G7 Countries (%), 2016-

Thyroid Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2016-

Thyroid Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016-

Proportion of Thyroid Cancer to Oncology Clinical Trials, E7 Countries (%), 2016-

Thyroid Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2016-

Thyroid Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016-

Thyroid Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2016-

Thyroid Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2016-

Thyroid Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2016-

Thyroid Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2016-

Thyroid Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015

Thyroid Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016-

Thyroid Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2016-

Thyroid Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016-

Thyroid Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016-

Methodology
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
AstraZeneca Plc
Eisai Co., Ltd.
Pfizer Inc.
Novartis AG
GlaxoSmithKline Plc
Bayer AG
Sanofi
F. Hoffmann-La Roche Ltd.
Exelixis, Inc.
Quintiles Transnational Holdings Inc.
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll